fda stopping compounded tirzepatide Says Must Exit the Market Compounded Tirzepatide With B6 (Pyridoxine)

Tirzepatide is administered once weekly via subcutaneous injection, with a gradual dose escalation protocol to minimize gastrointestinal side effects

This can cause the estrogen metabolites to be reabsorbed from the intestines and go back into circulation.[ref] Calcium D-glucarate can suppress the beta-glucuronidase activity in the gut, thus increasing the number of estrogen metabolites that are excreted.[ref] Hormone Replacement Therapy: Hormone replacement therapy (HRT) in menopause is the replacement of naturally declining estrogen and progesterone levels with either synthetic or bioidentical hormones

While tirzepatide does not directly affect B12 absorption like metformin, reduced intake of animal productscommon during appetite suppressionmay lead to inadequate B12 levels

Metsera, founded in 2022, brings a pipeline of both oral and injectable treatments with different targets